Arteriosclerosis Flashcards
Arteriosclerosis
“hardening of the arteries”; it is a generic term reflecting arterial wall thickening and loss of elasticity.
Arteriolosclerosis
affects small arteries and arterioles and may cause downstream ischemic injury. The two vari-ants, hyaline and hyperplastic arteriolosclerosis
Mönckeberg medial sclerosis is
characterized by the pres-ence of calcif i c deposits in muscular arteries, usually centered on the internal elastic lamina
( not imp clinically)
Individuals > 50 years
Fibromuscular intimal hyperplasia
non-atherosclerotic process that occurs in muscular arteries larger thanarterioles.
An SMC & ECM-rich lesion
Such a healing response can cause substantial stenosis of the vessel; indeed such inti-mal hyperplasia underlies stent restenosis and is the major long-term limitation of solid organ transplants
Atherosclerosis
intimal lesions called atheromas (or atheromatous or atherosclerotic plaques) that impinge on the vascular lumen and can rupture to cause sudden occlusion.
Atheromatous plaques
are raised lesions composed of soft friable (grumous) lipid cores (mainly cholesterol and cholesterol esters, with necrotic debris) covered by fibrous caps
Factors
Genetic abnormalities Family history Increasing age Male gender
Modif i able Hyperlipidemia Hypertension Cigarette smoking Diabetes Inf l ammation
Hyperhomocysteinemia
Metabolic syndrome. Associated with central obesity
Clonal hematopoiesis.
Atheroma pathogenesis
begin at sites of intact, but dysfunctional, endothelium. These dysfunctional ECs exhibit increased permeability, enhanced leukocyte adhe-sion, and altered gene expression, all of which may con-tribute to the development of atherosclerosis.
Hemodynamic disturbances and atherosclerosis plaques
plaques tend to occur at ostia of exiting vessels, at branch points, and along the posterior wall of the abdominal aorta, where there is turbulent blood fl ow
Do not memorise
homozygous famil-ial hypercholesterolemia, caused by defective LDL receptors and inadequate hepatic LDL uptake, can lead to myocardial infarction by 20 years of age.
g., diabetes mel-litus, hypothyroidism) that cause hypercholesterolemia lead to premature atherosclerosis.
dominant lipids in atheromatous plaques are cho-lesterol and cholesterol esters.
Why is LDL implicated in atherosclerosis
hyperlipidemia, particularly hypercholesterolemia, can directly impair EC function by increasing local oxygen free radical production; among other things, oxygen free radicals accelerate NO decay, damping its vasodilator activity.
Pathogenesis continued
lipoproteins accumulate within the intima, where they are hypothesized to gen-erate two pathogenic derivatives, oxidized LDL and cho-lesterol crystals.
LDL is oxidized through the action of oxygen free radicals generated locally by macrophages or ECs and ingested by macrophages through the scav-enger receptor, resulting in foam cell formation.
What does oxidized LDL do
Oxidized LDL stimulates the local release of growth factors, cytokines, and chemokines, increasing monocyte recruitment, and also is cytotoxic to ECs and SMCs
Also trigger inflammation
minute extracel-lular cholesterol crystals found in early atherosclerotic lesions serve as signals that can activate innate immune cells such as monocytes and macro-phages to produce IL-1 and other pro-inflammatory mediators.
Inflammation in atherosclerosis
dysfunctional ECs express adhesion mol-ecules that promote leukocyte adhesion, in particular, monocytes and T cells which migrate into the intima under the inf l uence of locally produced chemokines.
Monocytes engulf lipoproteins, including oxidized LDL and small cholesterol crystals. Cholesterol crystals activate inflammasome and subsequent release of IL-1.Activated macrophages also pro-duce toxic oxygen species that drive LDL oxidation and elaborate growth factors that stimulate SMC proliferation.
T cells contribute to chronic inflammation
Fatty streak
Intimal SMC proliferation and ECM deposition lead to conversion of the earliest lesion, a fatty streak, into a mature atheroma, contributing to the progressive growth of atherosclerotic lesions
platelet-derived growth factor (released by locally adherent platelets, macrophages, ECs, and SMCs), fi broblast growth factor, and TGF-α. The recruited SMCs synthesize ECM (most notably collagen), which sta-bilizes atherosclerotic plaques.